Beam Therapeutics (BEAM) Return on Sales (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Return on Sales data on file, last reported at 0.03% in Q1 2026.

• On a quarterly basis, Return on Sales rose 12.0% year-over-year to 0.03% in Q1 2026; TTM through Mar 2026 was 0.0%, a 6.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 5.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.03%, down from 0.02% in the prior quarter.
• Over the last five years, Return on Sales for BEAM reached as high as 0.02% in Q4 2025 and fell as low as 0.15% in Q1 2025.
• Historically, Return on Sales has averaged 0.07% across 5 years, with a median of 0.06% in 2023.
• Across the five-year window, Return on Sales surged 33668 bps in 2022 and decreased 9 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.02% in 2022, then surged by 124 bps to 0.0% in 2023, then tumbled by 766 bps to 0.03% in 2024, then surged by 176 bps to 0.02% in 2025, then plunged by 235 bps to 0.03% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.03% in Q1 2026, 0.02% in Q4 2025, and 0.12% in Q3 2025.